相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathophysiology and Treatment of Enteric Hyperoxaluria
Celeste Witting et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F. Garrelfs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Investigational Therapies for Primary Hyperoxaluria
Anna Kletzmayr et al.
BIOCONJUGATE CHEMISTRY (2020)
Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation
Prince Singh et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up
Sander F. Garrelfs et al.
KIDNEY INTERNATIONAL (2019)
Metabolite diagnosis of primary hyperoxaluria type 3
Lawrence Greed et al.
PEDIATRIC NEPHROLOGY (2018)
Late diagnosis of primary hyperoxaluria type III
Emmanuel Richard et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Katharina Hopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Renal function can be impaired in children with primary hyperoxaluria type 3
Lise Allard et al.
PEDIATRIC NEPHROLOGY (2015)
Mechanisms of human kidney stone formation
Andrew P. Evan et al.
UROLITHIASIS (2015)
Primary Hyperoxaluria
Pierre Cochat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genetic determinants of urolithiasis
Carla G. Monico et al.
NATURE REVIEWS NEPHROLOGY (2012)
An update on primary hyperoxaluria
Bernd Hoppe
NATURE REVIEWS NEPHROLOGY (2012)
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3
Emma L. Williams et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Ruth Belostotsky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
The primary hyperoxalurias
Bernd Hoppe et al.
KIDNEY INTERNATIONAL (2009)
The primary hyperoxalurias: An algorithm for diagnosis
DS Milliner
AMERICAN JOURNAL OF NEPHROLOGY (2005)
分享论文
